Elevance Health Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +6.3%
EBITDA: -18.9%
EBIT: -16.2%
EPS: -4.5%
Free cash flow: +17.8%
Operating cash flow: +15.6%

Forward estimates

Revenue: -2.2%
EBITDA: +50.4%
EPS: +25.2%

Three-year CAGR

Revenue: +8.3%
EBITDA: -1.6%
EBIT: -1.4%
Net income: -1.3%
EPS: +0.8%
Free cash flow: -24.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.